🇺🇸 FDA
Patent

US 9382214

Processes for the preparation of uracil derivatives

granted A61KA61K9/146A61K9/1688

Quick answer

US patent 9382214 (Processes for the preparation of uracil derivatives) held by Neurocrine Biosciences, Inc. expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K9/146, A61K9/1688, A61P, A61P15/00